Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CYTOCHROME-P450 CYP2D6' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 28 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Steimer, W; Muller, B; Leucht, S; Kissling, W
      Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy

      CLINICA CHIMICA ACTA
    2. Williams, DG; Hatch, DJ; Howard, RF
      Codeine phosphate in paediatric medicine

      BRITISH JOURNAL OF ANAESTHESIA
    3. Geisler, SA; Olshan, AF
      GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: A Mini-HuGE review

      AMERICAN JOURNAL OF EPIDEMIOLOGY
    4. Kirchheiner, J; Brosen, K; Dahl, ML; Gram, LF; Kasper, S; Roots, I; Sjoqvist, F; Spina, E; Brockmoller, J
      CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages

      ACTA PSYCHIATRICA SCANDINAVICA
    5. Murphy, MP; Beaman, ME; Clark, LS; Cayouette, M; Benson, L; Morris, DM; Polli, JW
      Prospective GYP2D6 genotyping as an exclusion criterion for enrollment of a phase III clinical trial

      PHARMACOGENETICS
    6. Duzhak, T; Mitrofanov, D; Ostashevskii, V; Gutkina, N; Chasovnikova, O; Posukh, O; Osipova, L; Lyakhovich, VV
      Genetic polymorphisms of CYP2D6, CYP1A1, GSTM1 and p53 genes in a unique Siberian population of Tundra Nentsi

      PHARMACOGENETICS
    7. Strange, RC; Alldersea, J; Hoban, PR; Fryer, AA; Matthias, C; Jahnke, V; Jones, PW
      Genetic polymorphism and clinical outcome: identification of individuals at risk of a poor clinical outcome

      ALLERGY
    8. Hijikata, M; Miyakawa, H; Matsushita, M; Kako, M; Ohta, Y; Mishiro, S
      CYP2D6 polymorphism and the presence of anti-LKM-1 in patients with chronic hepatitis C

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    9. Wennerholm, A; Johansson, I; Massele, AY; Jande, M; Alm, C; Aden-Abdi, Y; Dahl, ML; Ingelman-Sundberg, M; Bertilsson, L; Gustafsson, LL
      Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype

      PHARMACOGENETICS
    10. Chida, M; Yokoi, T; Kosaka, Y; Chiba, K; Nakamura, H; Ishizaki, T; Yokota, J; Kinoshita, M; Sato, K; Inaba, M; Aoki, Y; Gonzalez, FJ; Kamataki, T
      Genetic polymorphism of CYP2D6 in the Japanese population

      PHARMACOGENETICS
    11. Jorge, LF; Eichelbaum, M; Griese, EU; Inaba, T; Arias, TD
      Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations

      PHARMACOGENETICS
    12. Fjordside, L; Jeppesen, U; Eap, CB; Powell, K; Baumann, P; Brosen, K
      The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine

      PHARMACOGENETICS
    13. Kortunay, S; Bozkurt, A; Bathum, L; Basci, NE; Calguneri, M; Brosen, K; Kayaalp, SO
      CYP2D6 polymorphism in systemic lupus erythematosus patients

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    14. ROSTAMIHODJEGAN A; LENNARD MS; WOODS HE; TUCKER GT
      METAANALYSIS OF STUDIES OF THE CYP2D6 POLYMORPHISM IN RELATION TO LUNG-CANCER AND PARKINSONS-DISEASE

      Pharmacogenetics
    15. MIYAKAWA H; MATSUSHIMA H; NARITA Y; HANKINS RW; KITAZAWA E; FUJIKAWA H; KIKUCHI K; MATSUSHITA M; ABE K; KAWAGUCHI N; MORIZANE T; KAKO M
      DIFFERENCES IN ANTIGENIC SITES, RECOGNIZED BY ANTI-LIVER-KIDNEY MICROSOME-1 (LKM-1) AUTOANTIBODY, BETWEEN HCV-POSITIVE AND HCV-NEGATIVE SERA IN JAPANESE PATIENTS

      Journal of gastroenterology
    16. STEIJNS LSW; VANDERWEIDE J
      ULTRARAPID DRUG-METABOLISM - PCR-BASED DETECTION OF CYP2D6 GENE DUPLICATION

      Clinical chemistry
    17. MCLELLAN RA; OSCARSON M; SEIDEGARD J; EVANS DAP; INGELMANSUNDBERG M
      FREQUENT OCCURRENCE OF CYP2D6 GENE DUPLICATION IN SAUDI-ARABIANS

      Pharmacogenetics
    18. LOVLIE R; DALY AK; IDLE JR; STEEN VM
      CHARACTERIZATION OF THE 16-KB AND 30+9-KB CYP2D6-XBAI-HAPLOTYPES(9)

      Pharmacogenetics
    19. LOVLIE R; DALY AK; IDLE JR; STEEN VM
      CHARACTERIZATION OF THE 16-KB AND 30+9-KB CYP2D6-XBAI-HAPLOTYPES(9)

      Pharmacogenetics
    20. MEYER UA; ZANGER UM
      MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG-METABOLISM

      Annual review of pharmacology and toxicology
    21. MASIMIREMBWA CM; HASLER JA
      GENETIC-POLYMORPHISM OF DRUG-METABOLIZING-ENZYMES IN AFRICAN POPULATIONS - IMPLICATIONS FOR THE USE OF NEUROLEPTICS AND ANTIDEPRESSANTS

      Brain research bulletin
    22. DALY AK; FAIRBROTHER KS; ANDREASSEN OA; LONDON SJ; IDLE JR; STEEN VM
      CHARACTERIZATION AND PCR-BASED DETECTION OF 2 DIFFERENT HYBRID CYP2D7P CYP2D6 ALLELES ASSOCIATED WITH THE POOR METABOLIZER PHENOTYPES/

      Pharmacogenetics
    23. LUCOTTE G; TURPIN JC; GERARD N; PANSERAT S; KRISHNAMOORTHY R
      MUTATION FREQUENCIES OF THE CYTOCHROME CYP2D6 GENE IN PARKINSON DISEASE PATIENTS AND IN FAMILIES

      American journal of medical genetics
    24. ANWAR WA; ABDELRAHMAN SZ; ELZEIN RA; MOSTAFA HM; AU WW
      GENETIC-POLYMORPHISM OF GSTM1, CYP2E1 AND CYP2D6 IN EGYPTIAN BLADDER-CANCER PATIENTS

      Carcinogenesis
    25. MASIMIREMBWA C; HASLER J; BERTILSSONS L; JOHANSSON I; EKBERG O; INGELMANSUNDBERG M
      PHENOTYPE AND GENOTYPE ANALYSIS OF DEBRISOQUINE HYDROXYLASE (CYP2D6) IN A BLACK ZIMBABWEAN POPULATION - REDUCED ENZYME-ACTIVITY AND EVALUATION OF METABOLIC CORRELATION OF CYP2D6

      European Journal of Clinical Pharmacology
    26. TRANSON C; LECOEUR S; LEEMANN T; BEAUNE P; DAYER P
      INTERINDIVIDUAL VARIABILITY IN CATALYTIC ACTIVITY AND IMMUNOREACTIVITY OF 3 MAJOR HUMAN LIVER CYTOCHROME-P450 ISOZYMES

      European Journal of Clinical Pharmacology
    27. LOVLIE R; DALY AK; MOLVEN A; IDLE JR; STEEN VM
      ULTRARAPID METABOLIZERS OF DEBRISOQUINE - CHARACTERIZATION AND PCR-BASED DETECTION OF ALLELES WITH DUPLICATION OF THE CYP2D6 GENE

      FEBS letters
    28. PANSERAT S; MURA C; GERARD N; VINCENTVIRY M; GALTEAU MM; JACQZAIGRAIN E; KRISHNAMOORTHY R
      AN UNEQUAL CROSS-OVER EVENT WITHIN THE CYP2D GENE-CLUSTER GENERATES ACHIMERIC CYP2D7 CYP2D6 GENE WHICH IS ASSOCIATED WITH THE POOR METABOLIZER PHENOTYPE/

      British journal of clinical pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 18:14:15